Adipocyte-CM treated breast cancer cells upregulated the levels of mesenchymal markers (Vimentin and Zeb1) and downregulated epithelial marker (E-cadherin) (Figs 4a,b and S5a) indicating that adipocyte CM can promote EMT. This evidence concerns the gene CDH1 and breast carcinoma.